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Background: CHARGE syndrome is a complex multiple congenital malformation disorder with variable expres-
sion that is caused by mutations in the CHD7 gene. Variable heart defects occur in 74% of patients with a CHD7
mutation, with an overrepresentation of atrioventricular septal defects and conotruncal defects — including
arch vessel anomalies.
Methods and results:We report an index patient with an arch vessel anomaly underlying serious feeding prob-
lems that resolved after arch vessel surgery. This led us to examine the incidence of arch vessel anomalies in
our previously studied cohort of 299 patients with a CHD7 mutation. Forty-two patients (14%) had an aortic
arch anomaly, mostly aberrant subclavian artery or right aortic arch, which usually occurred in combination
with other congenital heart defects (81%). The majority of these patients also had feeding problems that may
be linked to their arch anomaly, but insufﬁcient information was available to exclude other causes.
Conclusions: Arch vessel anomalies occur in a signiﬁcant proportion of patients with a CHD7mutation, and these
anomalies may cause morbidity due to compression of the esophagus or trachea. Since symptoms of vascular
compression can mimic those caused by other abnormalities in CHARGE syndrome, it is important to be aware
of arch vessel anomalies in this complex patient category. Whether a solitary arch vessel anomaly is an indicator
for CHARGE syndrome still needs to be studied, but doctors should look out for other CHARGE syndrome features
in patients with arch vessel anomalies.
© 2016 The Authors. Published by Elsevier Ireland Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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1. Introduction
CHARGE syndrome (MIM 214800, Coloboma,Heart disease, Choanal
atresia, Retardation of growth and/or development, Genital hypoplasia
and Ear abnormalitieswith orwithout deafness) is amultiple congenital
malformation disorder with variable expression and an incidence of
5.8–6.7 per 100,000 newborns [1]. CHARGE syndrome is usually a spo-
radic condition that is caused, in particular, by de novo loss-of function
mutations in the CHD7 gene (MIM 608892) [2].
Congenital heart defects occur in 74% of patients who have CHARGE
syndrome due to a CHD7 mutation, and in 80% of patients with a
truncating CHD7 mutation [3]. Our previous study showed that while
the types of heart defects found in CHARGE syndrome patients are
variable, atrioventricular septal defects and conotruncal defects are
overrepresented compared to typically non-syndromic heart defects
[3]. Congenital arch vessel anomalies such as aberrant right subclavian
artery (ARSA) were highly overrepresented within our group of
patients with CHARGE syndrome [3].
The aortic arch and its vessels are formed after the fourth week of
embryogenesis by remodeling and re-arrangement of the aortic sac,
the branchial arch arteries and the dorsal root aorta's. An embryo devel-
oping normally initially has one aortic sac which communicates with
the heart via the truncus arteriosus and is connected to two dorsal
root aortas via paired branchial arch arteries. The eventual left sided
aortic arch derives from the aortic sac, left 4th branchial arch artery
and left dorsal root aorta. The ﬁrst origin, the brachiocephalic trunk,
arises from the aortic sac. The right and left common carotid arteries de-
velop from the 3rd branchial arch arteries. The root and ﬁrst part of the
right subclavian artery is formed by the right 4th branchial arch artery
and right dorsal root aorta. The rest of the right subclavian artery and
the complete left subclavian artery derive froman intersegmental artery
that originates directly from the dorsal root aorta. Themolecular control
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of this complex process is not well understood, but defective remodel-
ing results in congenital arch vessel anomalies [4–6].
A common congenital arch vessel anomaly is an aberrant subclavian
artery in which the right or left subclavian artery has an abnormal ana-
tomical position. An aberrant right subclavian artery, which is also
called arteria lusoria, passes posterior to the esophagus and left aortic
arch. It occurs when the right fourth branchial arch artery and proximal
portion of the right dorsal root aorta disappears, while the distal right
dorsal root aorta persists [6]. Aberrant subclavian arteries have been
found in 1–2% of pediatric patients who had echocardiograms and in
cardiac autopsy specimens [7,8]. Another frequent arch vessel abnor-
mality is a right-sided aortic arch (RAA) which is caused by the persis-
tence of the right dorsal root aorta and disappearance of the left
fourth branchial arch artery and left dorsal root aorta [6]. A RAA is usu-
ally associated with a congenital heart malformation [8,9].
Arch vessel anomalies are usually asymptomatic, but problems may
occur when a complete or incomplete vascular ring causes compression
of the esophagus and the trachea. A double aortic arch in which both
left- and right-sided aortic arches surround the trachea and esophagus
is themost common cause of vascular compression in children [10]. Pre-
senting symptoms of vascular compression vary, but include recurrent
respiratory infections, stridor, wheezing, cough, dyspnea, respiratory
distress, dysphagia, feeding difﬁculties and vomiting [5,10].
In this study we describe CHARGE patients with congenital arch
vessel anomalies and focus on the health problems thatmight be caused
by arch vessel anomalies in these patients.
2. Patients and methods
2.1. Case report
We report a clinically diagnosed CHARGE patient with dysphagia
due to an arch vessel anomaly. Clinical information was obtained
from the extensive medical correspondence concerning this patient.
The patient's parents have given consent for the publication of this
data.
2.2. Cohort of patients with an arch anomaly and a CHD7 mutation
We previously studied heart defects in 299 patients with a proven
CHD7 mutation, of whom 220 had a congenital heart defect [3]. This
cohort consisted of patients tested for a CHD7 mutation because of a
clinical suspicion of CHARGE syndrome. The CHD7 analysis was
performed on a diagnostic basis at the DNA laboratory in Nijmegen,
The Netherlands, between 2004 and 2009. Patients lived in The
Netherlands (34%) and other European countries (54%), but also on
other continents (12%). The accredited Medical Ethics Review Commit-
tee of the University Medical Center Groningen waived full ethical
evaluation because, according to Dutch guidelines, no ethical approval
is necessary if medical information that was already available is used
anonymously and no extra tests have to be performed.
We selected patients from this previous study who had a vascular
ring of any type, a RAA, an interrupted aortic arch, an aberrant left or
right subclavian artery, or an aberrant origin of an aortic arch vessel.
We studied cardiac phenotype and extra-cardiovascular symptoms in
these patients. The patient described in the case report was not part of
this cohort.
2.3. Control cohort to compare extra-cardiovascular features
The data collected about our study cohort were compared descrip-
tively to a previously published group of 280 CHARGE patients with a
known CHD7 mutation [2]. Because there is some overlap between
this group and our present study group, statistical comparisons were
not possible. However, excluding these overlapping patients described
here might bias the control group.
3. Results
3.1. Case report
We report new ﬁndings on a twenty-year-old male with CHARGE
syndrome. He was born after an uneventful full-term pregnancy and
with a birth weight of 8 lb (about 3500 g). He was evaluated directly
after birth because of congenital anomalies and respiratory distress.
He was diagnosed with laryngomalacia and had a tracheostoma until
he was 8.5 years old. A diagnosis of CHARGE syndrome (which was
then still an association) was made based on the combination of
following anomalies: colobomata of the optic nerve and fundus, choanal
stenosis, pulmonary valve dysplasia, genital hypoplasia with unilateral
cryptorchism, small kidneys with subcortical cysts, a grade IV
vesicoureteral reﬂux, velopharyngeal incompetence (due to 9th and
10th cranial nerve dysfunction), right sided facial nerve palsy and exter-
nal ear anomalies with absent response to BAER. Further evaluation
during the years showed profound sensorineural deafness with absent
auditory nerves, absent semicircular canals, dysplastic cochlea, anos-
mia, hypogonatropic hypogonadism and signiﬁcant short stature with
growth hormone deﬁciency. He had a normal conventional karyotype,
but CHD7 analysis had never been done. He does fulﬁll the current
diagnostic criteria for CHARGE syndrome [11,12].
The boy experienced feeding problems from birth, for which he re-
ceived tube feeding until the age of 9 years. Even after decannulation
and removal of the feeding tube, his feeding problems persisted; he as-
pirated water and could only eat soft foods. He had several swallowing
studies done through the years that showed a constriction of the esoph-
agus. From the age of 10 years his esophagus was dilated several times,
but his feeding problems did not improve. He had several periods of
choking, which warranted further evaluation. At the age of 18 years,
he had a gastroscopy, which indicated a vessel compressing the esoph-
agus. An angiogram conﬁrmed an aberrant right subclavian artery as the
cause. After surgical re-implantation of the aberrant subclavian artery,
the boy was ﬁnally able to eat normally, and no new feeding problems
or periods of choking have occurred since that time.
3.2. Arch vessel anomalies in a cohort of patients with a CHD7 mutation
Of the 299 patients with a CHD7mutation, 42 had a congenital arch
vessel anomaly (14%). This group consists of 23 males and 19 females
(see Table 1). Most patients had a truncating CHD7 mutation (33/42,
79%). Fourteen patients were deceased (33%), ten of the twelve patients
for whom the age of death was known died in the ﬁrst year of life
(see Table 1).
Right sided aortic arch (20 patients) and aberrant subclavian arteries
(19 patients) were most frequently identiﬁed (see Table 1). A vascular
ringwas identiﬁed in ﬁve patients. An abnormal origin of an arch vessel
was diagnosed in four patients, two concerning the subclavian artery
(patient 1 and 37) and two the carotid arteries (patient 17 and 20). In
patient 1, whohad an interrupted aortic arch type B and amalalignment
ventricular septal defect, the subclavian artery derived from the
descending aorta. In patient 37, who had a right-sided aortic arch and
a bicuspid aortic valve, the left subclavian artery derived from the pul-
monary artery. Patient 17 had a persistent ductus arteriosus (PDA)
and ARSA in combination with a right internal carotid artery that was
inserted higher than usual. Patient 20 had a PDA and ARSA with a
truncus bicaroticus, which means both carotid arteries originated from
one common origin of the aortic arch.
Most patients had other heart defects in addition to their arch vessel
anomaly (34/42, 81%), and one patient had a congenital conduction dis-
order. Interestingly, seven patients (17%) had an arch vessel anomaly as
an isolated cardiovascular feature (see Table 1). The accompanying
heart defects were variable, but often included septal defects (atrial as
well as ventricular), PDA and tetralogy of Fallot or double outlet right
ventricle.
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The most common extracardiovascular features were external ear
anomaly (36/36), hearing loss (34/34) and semicircular canal abnor-
malities (23/24), which were present in almost all patients for whom
the information was known (see Table 2). Developmental delay, genital
hypoplasia (e.g. micropenis or hypogonatropic hypogonadism) and cra-
nial nerve dysfunction were present in the majority of patients (N80%).
These extracardiovascular features did not clearly differ between our
study cohort and the control cohort (see Table 2).
Information on feeding or swallowing history was known for 26 of
37 patients who were alive at the age of 1 month. Only one out of
these 26 patients was recorded not to have feeding or swallowing
problems. Thus, these problems were present in 96% of patients
(range 25/37–36/37 = 68–97%). Remarkably, at least twenty patients
(77%, range 20/37–36/37 = 54–97%) had feeding problems that
necessitated tube feeding. Information on feeding was known for 110
patients in our control cohort, and tube feeding was necessary in 90
patients (82%, range 90/280–260/280=32–93%).We have no informa-
tion on recurrent respiratory infections, stridor, wheezing, cough or
dyspnea in both our study and control group.
4. Discussion
In our study cohort, arch vessel anomalies were present in 14%
(42/299) of patients with a CHD7 mutation and in 19% (42/220) of
patients with a CHD7mutation and a cardiovascular defect. We might
have missed patients with an arch vessel anomaly in our retrospective
study because it can be missed with echocardiography, and because
we know the collected data are not complete. We also did not have
enough information to classify heart defects in 18 patients (8%), and
in approximately 60% we had to base our classiﬁcation on the informa-
tion from the medical doctor who requested the CHD7 analysis.
Several previous studies on smaller populations (between 47 and 83
patients) also documented arch vessel anomalies in 4 to 23% of the pa-
tients with CHARGE syndrome, or in 5 to 36% of the patients with
CHARGE syndrome and a heart defect [13–16]. However the data from
our study and the previous studies cannot easily be compared for a
number of reasons. First, not every study used the same deﬁnition for
arch vessel anomalies, while the type of heart defects that are catego-
rized as arch vessel anomaly are not clear in others. For example, we
did not include hypoplastic aortic arch as an arch vessel anomaly
based on the classiﬁcation system we used to classify heart defects
[17,18], while a previous study did [16]. Second, we included patients
with arch vessel anomalies and other cardiac anomalies in our percent-
ages while, in at least one other study, patients with an arch vessel
anomaly and another heart defect were partly categorized in a different
group [16]. Finally, the populations differ because patients in all previ-
ous studies had a clinically based diagnosis of CHARGE syndrome,
while we included only patients with a deﬁnite molecular diagnosis.
Nonetheless, both our study and all previous studies show that arch
vessel anomalies do occur more frequently in CHARGE syndrome than
in the general population.
We primarily identiﬁed patients with aberrant subclavian arteries
and right-sided aortic arch in our cohort, but rarer arch vessel anomalies
can also occur in patients with CHARGE syndrome. For example, we
identiﬁed an abnormal origin of an arch vessel in four of our patients
(see Table 1). An aberrant origin has also been described previously in
CHARGE patients for the left brachiocephalic trunk and left subclavian
artery out of the pulmonary artery, respectively [19,20]. In our study co-
hort, the arch vessel anomalies usually occurred in combination with
other heart defects. However, it is important to note that arch vessel
anomalies such as right aortic arch and aberrant subclavian artery
were solitary in 17% of our patient cohort.
Based on these clinical observations, CHD7 probably has an effect on
the embryonic development of the branchial arch arteries. This hypoth-
esis is supported by animal studies in which knockdown of CHD7
has been shown to have an effect on pharyngeal arch development
[21,22]. We did not ﬁnd an indication that truncating mutations in
CHD7 are more likely to be the cause of arch vessel anomalies, as they
were present in comparable percentages in our study and control cohort
(79% vs. 71%), while they are known to be present signiﬁcantly more
often in CHARGE patients with a congenital heart defect [3].
CHARGE syndrome is a complex multiple congenital malformation
disorder. Children with CHARGE syndrome face signiﬁcant problems.
Feeding problems, chronic aspiration and swallowing dysfunction are
often present and can result in recurrent respiratory infections [23,24].
Identifying the cause of feeding problems in CHARGE syndrome is com-
plex, because they can be associatedwith structural problems of the oral
cavity, the nasal cavity, the pharynx or larynx; cranial nerve defects;
congenital heart defects; or a combination of factors. Since respiratory
aspiration is a risk factor for early death in CHARGE syndrome, it is im-
portant to carefully evaluate feeding problems [25]. A vascular ring,
caused by an arch vessel anomaly, may present as feeding problems
Table 1
Overview of 42 patients with a CHD7mutation and an arch vessel anomaly.
Mutation type Arch vessel anomaly Other heart defect
1a f Fs Aberrant origin SA, IAA VSD
2 m Fs ASA PS
3a f Fs ASA, IAA AVSD, DORV
4 f Fs ASA ASD
5 f Fs ASA SAS
6 f Mis ASA VSD
7 m Non ASA Truncus
8 m Non ASA AVSD
9 m Non ASA ASD, BAV, VSD
10a f Non ASA ASD, coarctation, VSD
11 m Non ASA Fallot
12a f Non ASA, IAA Absent left AV valve, DORV
13a m Splice ASA Fallot, TAPVR
14 f Splice ASA PDA
15a f Splice ASA HLHS, coarctation
16 m Transl ASA ASD, PDA
17a m Non ASA, aberrant origin RCA PDA
18 m Mis ASA, RAA Peripheral PS
19 m Non ASA, RAA Coarctation
20 f Fs ASA, truncus bicaroticus PDA
21 m Fs RAA Fallot
22 f Fs RAA
23 f Fs RAA PDA
24a m Fs RAA Fallot
25 f Fs RAA
26 f Non RAA Coarctation, VSD
27 m Non RAA Coarctation, SAS, VSD
28 f Non RAA Fallot
29a f Non RAA
30a m Non RAA ASD, VSD
31 f Non RAA Fallot
32a m Non RAA
33 m Non RAA ASD, PDA
34a m Splice RAA DORV, VSD
35a m Splice RAA AVSD
36 m Splice RAA PDA
37a m Fs RAA, aberrant origin LSA BAV
38 m Fs Vasc. ring ASD, VSD
39 m Fs Vasc. ring
40 m Non Vasc. ring
41 f Splice Vasc. ring
42 f Non Vasc. ring, RAA
Sex: f, female; m, male.
Mutation type: Fs, frameshift; Mis, missense; Non, nonsense; Splice, splice site or intronic
variant; Transl, translocation t(2;8) (q11.2; q11.2).
Arch vessel anomalies: ASA, aberrant subclavian artery; LSA, left subclavian artery; RAA,
right aortic arch; RCA, right coronary artery; SA, subclavian artery; Vasc. ring, vascular ring.
Other heart defects: ASD, atrial septal defect; AVSD, atrioventricular septal defect; AV
valve, atrioventricular valve; BAV, bicuspid aortic valve; coarctation, coarctation aorta;
DORV, double outlet right ventricle; Fallot, tetralogy of Fallot; HLHS, hypoplastic left
heart syndrome; IAA, interrupted aortic arch; PDA, persistent ductus arteriosus; PS,
pulmonary stenosis; SAS, subvalvular aortic stenosis; TAPVR, total anomalous pulmonary
venous return; Truncus, truncus arteriosus; VSD, ventricular septal defect.
a Deceased.
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and respiratory problems. Our study indicates that arch vessel anoma-
lies are often present in patients with molecularly diagnosed CHARGE
syndrome, but we could not identify predictive factors for the existence
of an arch vessel anomaly, e.g. CHD7mutation type or other CHARGE-
related congenital malformations (see Table 2). Furthermore feeding
problems for which tube feeding was needed doesn't occur more
often in patients with arch vessel anomalies (83% range 48–90%) com-
pared to the control population of patients with a CHD7 mutation
(82%, range 32–93%, see Table 2). However, the medical history de-
scribed in our case report clearly illustrates that vascular compression
due to an arch vessel anomaly should be taken into account in patients
with CHARGE syndrome who also have respiratory and/or feeding
problems, especially when choking occurs. The exact prevalence of
symptomatic vascular compression of the trachea and/or esophagus in
CHARGE syndrome needs to be established.
Since 74% of the patients with molecularly proven CHARGE syn-
drome have a heart defect, an echocardiography is usually performed
in CHARGE patients [3]. However, a normal transthoracic echocardiog-
raphy does not exclude an arch vessel anomaly since its sensitivity for
detecting arch vessel anomalies is low [26]. To indicate the presence
of a vascular ring, a regular chest X-ray for tracheal compression, and
barium contrast esophagography for esophageal compression, respec-
tively, have a higher sensitivity [9,26]. For identifying the exact mor-
phology of an arch vessel anomaly, non invasive imaging techniques
like magnetic resonance imaging and computed tomography are
warranted, and they can be used with the same efﬁciency as invasive
Table 2
Other features of CHARGE syndrome in patients with arch vessel anomalies.
Patient C A DD GR G E HL SCC CLP F CN
1a f y y ? ? ? y ? y ? ? ?
2 m n n y n y y y y n y y
3a f y y ? ? ? y y y n n ?
4 f n ? ? ? ? y y ? y ? ?
5 f y y y y ? ? y ? ? y ?
6 f n n ? y ? ? ? n n y ?
7 m n n y ? y y ? y ? yc y
8 m y n y y ? y y y ? y ?
9 m y ? ? ? y y y y y yb y
10a f ? ? ? ? ? y y ? y ? ?
11 m ? ? y ? y ? y ? ? ? ?
12a f n y ? ? ? ? ? ? ? ? ?
13a m y n ? n ? y ? ? y ? ?
14 f y n y y y y y ? n ? y
15a f y n ? ? ? y ? ? y ? ?
16 m n y ? y y y y ? y y y
17a m y n ? y y y y ? ? yb,c y
18 m y ? ? ? y y ? ? ? ? y
19 m n y ? n y y y y n y ?
20 f y n y n ? y y y ? ?c ?
21 m y n y n y y y y n ? y
22 f n ? y ? ? y y y y y n
23 f y ? ? ? ? y y ? ? ? y
24a m n y ? n y y y y n ? ?
25 f ? y y ? ? ? y ? ? ? ?
26 f y n n y n y y y n y y
27 m y y ? n n y y y n y y
28 f y n n y ? y y y n y y
29a f y y y y n y y y n y y
30a m y y ? ? ? y y ? ? yb ?
31 f y ? y y ? y y ? ? yc y
32a m y n y ? ? y y y y y n
33 m n n y y y y y ? n y ?
34a m y n ? y y y y y ? yc ?
35a m n n y y y y y ? n ? y
36 m y n ? y y y y y y ? n
37a m y y ? ? y y ? y n ? y
38 m n n y y n y y ? y y y
39 m y y n n y y y y n y ?
40 m y n ? n y y y y n y y
41 f n n y y ? ? y y y ?c ?
42 f n y y n ? y y y n y y
Total 25/39 14/34 18/21 16/26 18/22 36/36 34/34 23/24 11/28 20/24 19/22
% 64 41 86 62 82 100 100 96 39 83 86
Range% 60–67 33–52 43–93 38–76 43–90 86–100 81–100 55–98 26–60 48–90 45–93
Control % 81 55 99 37 81 97 ? 94 48 82 99
Control
Range%
68–84 35–71 53–99 13–79 42–90 80–98 ? 39–98 28–70 32–93 62–100
m, male; f, female; y, feature present; n, feature absent; ?, unknown/no information.
C, Coloboma or microphthalmia; A, Choanal atresia or stenosis; DD, Developmental delay: GR, growth retardation; G, genital hypoplasia, e.g. micropenis, hypogonadotropic
hypogonadism; E, external ear anomaly; HL, hearing loss; SCC, semicircular canal anomaly, CLP, cleft lip and or palate; F, feeding problems, needing tube feeding.
Total, patients inwhom featurewaspresent/all patients ofwhom informationwas known;%, percentage of patients ofwhom informationwas knownwhohad this feature; Range%, shows
the minimum–maximum frequency of a feature in this cohort as calculated by (positive/total) × 100%− (positive + unknown/total) × 100%; Control, numbers based on a previously
studied cohort of 280 patients with a pathogenic CHD7mutation [2].
a Deceased.
b No information on tube feeding, not included in total number of patients.
c Swallowing problems are mentioned.
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angiographic techniques, which has been the gold standard for decades
[9,27]. The identiﬁcation of abnormal aortic arch arteries can also be
important for asymptomatic CHARGE syndrome patients who need
interventional or surgical procedures because routine procedures may
be complicated in patients with arch vessel anomalies, e.g., when
associated with anomalies of the laryngeal nerve.
Given the high prevalence of arch vessel anomalies in CHARGE syn-
drome, it remains interesting to study how often patientswith arch ves-
sel anomalies have a CHD7 mutation. Our recent study in 46 patients
with syndromic conotruncal heart defects or AVSD, including eight
with an arch vessel anomaly, did not identify any pathogenic CHD7mu-
tations [28]. In a previous study that focused on the prevalence of
bicarotid trunk in patients who underwent cardiac catheterization, ge-
netic syndromes were also assessed; CHARGE syndrome was present
in three of the 310 patients (1%) with a bicarotid trunk [29]. A study
of 257 patients with a tetralogy of Fallot with pulmonary stenosis
showed that the incidence of chromosomal or genetic abnormalities, in-
cluding CHARGE syndrome, increased signiﬁcantly in patients who had
an aberrant subclavian artery with either a left or right aortic arch [30].
While we don't yet have enough support to advise CHD7 analysis in all
patients with arch vessel anomalies, current studies suggest arch vessel
anomaliesmight be an indicator of CHARGE syndrome.We therefore do
advise health care professionals to look carefully for other features of
CHARGE syndrome (e.g. external ear anomalies, balance problems,
deafness and coloboma) in patients with arch vessel anomalies.
In conclusion, arch vessel anomalies are present in a signiﬁcant por-
tion of patients with a CHD7mutation. Theymay cause problems due to
compression of the esophagus and/or trachea. Therefore, doctors caring
for patients with CHARGE syndrome should be aware of this underlying
and treatable cause of swallowing and respiratory problems. Future
studies arewarranted to identifymore precisely the frequency of symp-
tomatic arch vessel anomalies in CHARGE syndrome. More evidence is
needed to support that an arch vessel anomaly is an indicator of
CHARGE syndrome, but doctors should be aware of other features of
this complex entity in patients with an arch vessel anomaly.
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